Development and validation of criteria to identify medication-monitoring errors in care home residents

International Journal of Pharmacy Practice

Volumn 16, Issue 5, 2008, Pages 317-323

  Alldred, David P ^a   Standage, Claire ^a   Zermansky, Arnold G ^a   Jesson, Barbara ^b   Savage, Imogen ^b   Franklin, Bryony Dean ^b,c   Barber, Nick ^b   Raynor, David K ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AZATHIOPRINE; CARBIMAZOLE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; LEVOTHYROXINE; LITHIUM DERIVATIVE; METHOTREXATE; PENICILLAMINE; POTASSIUM; SALAZOSULFAPYRIDINE; THEOPHYLLINE; VALPROIC ACID; WARFARIN;

ARTICLE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; ELDERLY CARE; GENERAL PRACTICE; GENERAL PRACTITIONER; HOME CARE; HOME MONITORING; HUMAN; MAINTENANCE THERAPY; MEDICATION ERROR; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 52649103577     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.16.5.0007     Document Type: Article

References (20)

1. Armour D, Cairns C, editors. Medicines in the elderly. London: The Pharmaceutical Press; 2002.
2. Furniss L, Burns A, Craig SKL, Scobie S, Cooke J, Faragher B. Effects of a pharmacist's medication review in nursing homes: randomised controlled trial. Br J Psychiatry 2000; 176:563-7.
3. Oborne CA, Hooper R, Swift GC, Jackson SHD. Explicit, evidence-based criteria to assess the quality of prescribing to elderly nursing home residents. Age Ageing 2003; 32;102-8.
4. Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, Bowie P. Clinical medication review by a pharmacist of elderly people living in care homes-randomised controlled trial. Age Ageing 2006;35(6):586-91.
5. Department of Health and Ageing. National Medicines Policy: Quality Use of Medicines. http://www.health.gov.au/intemet/main/publishing.nsf/ Conten/nmp-quality.htm (accessed May 19, 2008).
6. Expert Group on Learning from Adverse Events in the NHS. An organisation with a memory. London: Stationery Office; 2000.
7. Department of Health. Building a safer NHS for patients. London: Department of Health; 2001.
8. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary, 51st ed. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2006.
9. Monitoring drug therapy. North West Drug Information Letter no. 120, September 2002. http://www.ukmi.nhs.uk/newmaterial/html/docs/ 21100201.pdf (accessed December 6, 2007).
10. Suggestions for Drug Monitoring in Adults in Primary Care: a collaboration between London and South East Medicines Information Service and Croydon Primary Care Trust. 2008. http://www.nelm.nhs.uk/ Documents/Drug%20Monitoring%20Document%20-final%20%20Version%20 (Apr%2008)%20-%20national.pdf?id=593736 (accessed June 13, 2008).
11. Hinchingbrooke Hospital NHS Trust. Monitoring of maintenance therapy in primary care. Huntingdon: Hinchingbrooke Hospital NHS Trust; 2005.
12. Beers MH, Ouslander JG, Fingold SF et al. Inappropriate medication prescribing in skilled nursing-home facilities. Ann Intern Med 1992;117:684-9.
13. Perri M, Menon AM, Deshpande AD et al. Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 2005;39:405-11.
14. Sloane PD, Zimmerman S, Brown LC, Ives TJ, Walsh JF. Inappropriate medication prescribing in residential care/assisted living facilities. J Am Ger Soc 2002;50(6):1001-11.
15. Gray SL, Hedrick SC, Rhinard EE, Sales AE, Sullivan JH, Tomatore JB, Curtis MP. Potentially inappropriate medication use in community residential care facilities. Ann Pharmacother 2003;37:988-93.
16. Shekelle PG, MacLean CH, Morton SC, Wenger NS. Assessing care of vulnerable elders: methods for developing quality indicators. Ann Intern Med 2001;135:647-52.
17. Gurwitz JH, Field TS, Judge J, Rochon P, Harrold LR, Cadoret C, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005;118(3):251-8.
18. Alldred DP, Zermansky AG, Petty DR, Raynor DK, Freernantle N, Eastaugh J, Bowie P. Clinical medication review by a pharmacist of elderly people living in care homes: pharmacist interventions. Int J Pharm Pract 2007;13:93-9.
19. Morris CJ, Rodgers S, Hammersley VS, Avery AJ, Cantrill JA. Indicators for preventable drug-related morbidity: applications in primary care. Qual Saf Health Care 2004;13;181-5.
20. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47.